Politiparty
Politiparty

119th Congress Health

H.R. 2343: John W. Walsh Alpha-1 Home Infusion Act of 2025

Introduced

  1. Introduced (completed)Mar 25, 2025
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Mar 25, 2025

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

60

Bipartisan support.

Who scored on this bill

18 points earned
  1. 1Maria Salazar R-FL SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone4 events+18
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Maria Salazar

History

  1. Mar 25, 2025Introduced in the House by Maria Salazar.
Show the full action history (2 actions)
  1. Mar 25, 2025Introduced in House
  2. Mar 25, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.